Brown Brothers Harriman & CO Merck & Co., Inc. Transaction History
Brown Brothers Harriman & CO
- $14 Billion
- Q3 2024
A detailed history of Brown Brothers Harriman & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 234,454 shares of MRK stock, worth $22.4 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
234,454
Previous 234,034
0.18%
Holding current value
$22.4 Million
Previous $29 Million
8.11%
% of portfolio
0.19%
Previous 0.23%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,816Shares Held
1.86BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$23.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.24 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.65 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $242B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...